Blocking S1P4 signaling attenuates brain injury in mice with ischemic stroke

초록

Introduction: The functions of S1P receptors have been revealed using genetic and pharmacological tools, including the potent non-selective modulator FTY720. However, studies on subtype-specific agonists and antagonists are limited; hence, the role of S1P4 remains unclear. Objectives: To identify a novel function of S1P4 as a pathogenic factor in stroke using a newly developed S1P4-selective modulator and S1P4 knockdown. Methods: Heteroaromatic analogs of FTY720 were synthesized, a b-arrestin assay was conducted against S1P receptors, and the developed compound (NXC736) was characterized as a functional S1P4 antagonist. To clarify the function of S1P4, the therapeutic potential of NXC736 in ischemic stroke was determined using a transient middle cerebral artery occlusion (tMCAO) mouse model, which was validated using S1P4 knockdown. The S1P4-dependent pathogenic mechanisms were determined using immunohistochemical and biochemical analyses. Results: Molecular modeling studies provide valuable clues for understanding S1P4 selectivity of NXC736. NXC736 contains a triazole ring instead of a phenyl ring and exhibits S1P4-selective activity as a functional antagonist. Its action on S1P4 does not require phosphorylation by sphingosine kinase 2. Notably, NXC736 exhibited substantial therapeutic activity against ischemic stroke by attenuating tMCAO-induced acute brain injuries, including brain infarction, neurological deficits, and neuronal apoptosis. This suggested that S1P4 is a pathogenic factor in ischemic stroke. This function was confirmed using AAV-based S1P4 knockdown. NXC736 or S1P4 knockdown attenuated blood-brain barrier disruption, neutrophil infiltration, microglial activation and proliferation, and the upregulation of pro-inflammatory cytokines, thereby demonstrating that S1P4 influences neuroinflammatory responses in ischemic stroke. The underlying mechanisms were activation of NLRP3 inflammasome, NF-KB, and MAPKs. S1P4 also contributed to chronic brain injuries caused by ischemic stroke because NXC736 exerted long-term neuroprotective effects against tMCAO challenge. Conclusion: Using a functional S1P4 antagonist (NXC736) and a genetic tool for S1P4 knockdown, we iden-tified S1P4 as a novel pathogenic factor in ischemic stroke. (c) 2025 Published by Elsevier B.V. on behalf of Cairo University. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

키워드